Citas bibligráficas
Huamán, B., Mateo, A. (2023). Reacciones adversas a fármacos antituberculosos durante el tratamiento para tuberculosis en pacientes atendidos en el centro de salud la libertad, Huancayo 2022 [Universidad Privada de Huancayo Franklin Roosevelt]. http://repositorio.uroosevelt.edu.pe/handle/20.500.14140/1390
Huamán, B., Mateo, A. Reacciones adversas a fármacos antituberculosos durante el tratamiento para tuberculosis en pacientes atendidos en el centro de salud la libertad, Huancayo 2022 []. PE: Universidad Privada de Huancayo Franklin Roosevelt; 2023. http://repositorio.uroosevelt.edu.pe/handle/20.500.14140/1390
@misc{renati/691630,
title = "Reacciones adversas a fármacos antituberculosos durante el tratamiento para tuberculosis en pacientes atendidos en el centro de salud la libertad, Huancayo 2022",
author = "Mateo Diaz, Anamin Sarai",
publisher = "Universidad Privada de Huancayo Franklin Roosevelt",
year = "2023"
}
The objective was to identify adverse reactions to antituberculosis drugs during treatment for tuberculosis in patients treated at the Centro de Salud la Libertad, Huancayo 2022. As a method, the basic descriptive, observational, retrospective type was used. The sample consisted of 79 patients with tuberculosis. The results were as follows. 67.1% were mild adverse reactions, 20.3% were moderate, 12.7% were severe and 34.2% affected the gastrointestinal system, 30.4% affected the skin and subcutaneous tissue, 20.3% affected the liver, 15.2% affected the immune system. In conclusion, 55.7% of the AARs were conditional and 44.3% probable; with respect to the drug suspected of AARs, 67.1% was rifampicin, which was associated with more adverse reactions, and 50.6% did not present any comorbidity.
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons